STOCK TITAN

Carmel Liron of Polyrizon (PLRZ) sells 942 shares, holds 3,127

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Polyrizon Ltd. director Carmel Liron reported an open-market sale of 942 Ordinary Shares at $12.36 per share. After this transaction, Liron directly holds 3,127 Ordinary Shares. These holdings consist of 521 ordinary shares and 2,606 restricted ordinary shares that vest in equal quarterly installments, subject to continued service.

Positive

  • None.

Negative

  • None.
Insider Carmel Liron
Role Director
Sold 942 shs ($12K)
Type Security Shares Price Value
Sale Ordinary Shares 942 $12.36 $12K
Holdings After Transaction: Ordinary Shares — 3,127 shares (Direct)
Footnotes (1)
  1. [object Object]
Shares sold 942 shares Open-market sale on 2026-03-31
Sale price $12.36 per share Ordinary Shares sale
Shares held after transaction 3,127 shares Director’s direct holdings following sale
Unrestricted ordinary shares held 521 shares Portion of post-transaction holdings
Restricted ordinary shares held 2,606 shares Vest quarterly, subject to continued service
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
restricted ordinary shares financial
"Consists of (i) 521 ordinary shares and (ii) 2,606 restricted ordinary shares"
Restricted ordinary shares are common stock that cannot be sold or transferred until certain conditions are met—such as a time period passing, performance targets being reached, or regulatory approvals—often issued to employees, founders, or early investors. They matter because those restrictions delay when the shares can enter the market, affecting the future supply of shares, potential dilution and company valuation; think of them as goods locked in a warehouse until release conditions are satisfied.
vest in equal installments financial
"restricted ordinary shares that vest in equal installments on a quarterly basis"
continued service financial
"vest in equal installments on a quarterly basis, subject to the Reporting Person's continued service"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Carmel Liron

(Last)(First)(Middle)
C/O POLYRIZON LTD.
9 HAPNINA STREET

(Street)
RAANANA4321546

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
Polyrizon Ltd. [ PLRZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares03/31/2026S942D$12.363,127(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Consists of (i) 521 ordinary shares and (ii) 2,606 restricted ordinary shares that vest in equal installments on a quarterly basis, subject to the Reporting Person's continued service.
/s/ Liron Carmel04/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Polyrizon (PLRZ) disclose for Carmel Liron?

Polyrizon disclosed that director Carmel Liron executed an open-market sale of 942 Ordinary Shares. The shares were sold at a price of $12.36 per share, as reported in a Form 4 insider trading filing with U.S. regulators.

How many Polyrizon (PLRZ) shares does Carmel Liron hold after the reported sale?

After the reported transaction, Carmel Liron directly holds 3,127 Ordinary Shares of Polyrizon. This position includes both regular and restricted shares, as detailed in the filing’s footnote, providing context for Liron’s remaining economic interest in the company.

At what price were Carmel Liron’s Polyrizon (PLRZ) shares sold?

The Form 4 shows that Carmel Liron’s 942 Ordinary Shares of Polyrizon were sold at an average price of $12.36 per share. This represents an open-market sale, rather than a grant, option exercise, or tax-withholding related disposition.

What portion of Carmel Liron’s Polyrizon (PLRZ) holdings are restricted shares?

According to the filing’s footnote, Carmel Liron’s post-transaction holdings include 2,606 restricted ordinary shares. These restricted shares vest in equal installments on a quarterly basis, contingent on Liron’s continued service with Polyrizon as specified in the disclosure.

How are Carmel Liron’s restricted Polyrizon (PLRZ) shares scheduled to vest?

The restricted ordinary shares held by Carmel Liron vest in equal installments on a quarterly basis. Vesting is conditioned on Liron’s continued service to Polyrizon, meaning the shares become fully owned over time as this service requirement is met.
Polyrizon Ltd

NASDAQ:PLRZ

View PLRZ Stock Overview

PLRZ Rankings

PLRZ Latest News

PLRZ Latest SEC Filings

PLRZ Stock Data

18.95M
1.61M
Biotechnology
Healthcare
Link
Israel
Ra'anana